HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Maybelline New York: L'Oreal USA brand launches Color Sensational lipcolor, a line of 48 lipstick shades positioned to answer the question "how do I find the perfect shade of lipcolor?" firm says April 17. Item contains "latest pigment and pearl technologies" and matching packaging clues consumers in to the color inside. Undiluted pigments in the item "impart crisp color with pure-payoff," and honey-nectar in the formula gives it a creamy, luxurious texture, L'Oreal claims. Products are grouped into four color families - reds, pinks, plums and naturals - that represent the top-selling hues from prestige and mass lip products. Color Sensational lipcolor will debut in June for $7.49

You may also be interested in...



Dermaray Light-Based Devices Treat Acne, Aging At Home

Australian firm TCG Industrial has introduced a pair of hand-held, battery-operated devices - for administering ultraviolet and laser phototherapy - that it says can be used at home to treat skin complaints ranging from psoriasis to acne to signs of aging

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016099

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel